US2006025580A1PendingUtilityA1
Novel human estrogen receptor beta
Est. expiryAug 5, 2017(expired)· nominal 20-yr term from priority
C07K 14/70567
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides isolated nucleic acids encoding full-length human estrogen receptor-β (hERβ), which comprises 530 amino acids. The invention also provides isolated hERβ polypeptides and hERβ-reactive antibodies, including those that specifically recognize amino acids 1-45 of hERβ. The invention also encompasses methods for identifying hERβ-interactive compounds, including agonists, antagonists, and co-activators.
Claims
exact text as granted — not AI-modified1 - 30 . (canceled)
31 . An isolated nucleic acid encoding a polypeptide, wherein said polypeptide comprises the amino acid sequence set forth in FIG. 4 (SEQ ID NO:2).
32 . The isolated nucleic acid of claim 31 , wherein said nucleic acid comprises the nucleotide sequence set forth in FIG. 3 (SEQ ID NO:1).
33 . The isolated nucleic acid of claim 31 , wherein said nucleic acid is DNA.
34 . The isolated nucleic acid of claim 31 , wherein said nucleic acid is RNA.
35 . A recombinant vector comprising a nucleic acid according to claim 31 .
36 . The recombinant vector of claim 35 , wherein the nucleic acid is operably linked to a transcription regulatory element.
37 . A host cell comprising a recombinant vector according to claim 35 .
38 . A host cell according to claim 37 , wherein the cell is a bacterial cell, a fungal cell, a plant cell, an insect cell or a vertebrate cell.
39 . A host cell according to claim 37 , wherein said cell expresses a polypeptide encoded by the recombinant vector.
40 . A method for producing a polypeptide, which method comprises incubating a cell according to claim 37 under conditions that permit expression of a heterologous polypeptide encoded by the recombinant vector.
41 . The method of claim 40 further comprising steps of:
(a) harvesting the incubated cells to produce (i) a cell fraction, and (ii) a medium fraction; and (b) recovering the polypeptide from the cell fraction, the medium fraction or both.
42 . A method for identifying compounds that interact with hERβ polypeptide, wherein the HERβ polypeptide comprises the amino acid sequence set forth in FIG. 4 (SEQ ID NO:2), and wherein said method comprises steps of:
(a) bringing a host cell into contact with one or more test compounds, said host cell being transformed with (i) an isolated nucleic acid encoding the hERβ polypeptide, and (ii) a reporter gene functionally linked to an estrogen-responsive promoter element; and (b) monitoring expression of the reporter gene, wherein a change in expression of the reporter gene identies a compound that interacts with the hERβ polypeptide.
43 . The method of claim 42 , further comprising a step of introducing into the host cell (i) the nucleic acid encoding hERβ polypeptide, and (ii) the reporter gene functionally linked to the estrogen-responsive reporter element.
44 . The method of claim 42 , wherein the nucleic acid encoding hERβ polypeptide comprises the nucleotide sequence set forth in FIG. 3 (SEQ ID NO:1).
45 . The method of claim 42 , wherein the estrogen-responsive promoter element is an estrogen response element.
46 . The method of claim 42 wherein the host cell is a HepG2 cell.
47 . The method of claim 42 , wherein the host cell is a HAECT-1 cell.
48 . The method of claim 42 , wherein the host cell is a COS cell, a HeLa cell, a CHO cell, a HUVEC cell, or a yeast cell.
49 . The method of claim 48 , wherein the host cell is a yeast cell.
50 . The method of claim 42 , wherein the reporter gene is a luciferase gene, a chloramphenicol acetyl transferase (CAT) gene, or a green fluorescence protein gene.
51 . The method of claim 50 , wherein the reporter gene is a luciferase gene.
52 . The method of claim 42 , wherein the reporter gene is a β-galactosidase gene.
53 . A method for identifying compounds that interact with hERβ polypeptide, wherein the HERβ polypeptide comprises the amino acid sequence set forth in FIG. 4 (SEQ ID NO:2), and wherein said method comprises steps of:
(a) introducing into a host cell (i) an isolated nucleic acid encoding the hERβ polypeptide, and (ii) a reporter gene functionally linked to an estrogen responsive promoter element; (b) brining the host cell into contact with one or more test compounds; and (c) monitoring expression of the reporter gene, wherein a change in expression of the reporter gene identies a compound that interacts with the hERβ polypeptide.Join the waitlist — get patent alerts
Track US2006025580A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.